NewsEvents

Your Yourlocation: Home > Clinical observation of tiotropium bromide(136310-93-5) in the treatment of chronic obstructive pulmonary disease

To analyze the clinical efficacy of tiotropium bromide(136310-93-5) in the treatment of chronic obstructive pulmonary disease. Studies have shown that patients with chronic obstructive pulmonary disease treated with tiotropium better than conventional drugs, can promote the improvement of clinical efficacy, worthy of further popularization and application. The article published in 2015 13th issue of "Chinese community physicians" magazine.

From August 2013 to August 2014, 80 patients with chronic obstructive pulmonary disease were randomly divided into control group and observation group. The control group was treated with ipratropium bromide and the observation group received tiotropium bromide(136310-93-5). After 14 days of treatment, the clinical efficacy of the two groups was observed.

The total effective rate of the observation group was 97.50% (39/40), which was significantly higher than that of the control group (75.00%, 30/40). The difference was statistically significant (P <0.05).

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved